===== phenotype 26=================================================================
===== phenotype 26=================================================================
proportion of pts: 0.0975803252678
lambda: 29076.7869051
----------------------------------------
Malignant neoplasm of digestive organs and peritoneum
Operations on the nose, mouth, and pharynx
Disorders of thyroid gland
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Na
Hereditary and degenerative diseases of the central nervous system
Other disorders of the central nervous system
Operations on the cardiovascular system
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Cerebrovascular disease
Diseases of arteries, arterioles, and capillaries
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Arthropathies and related disorders
Rheumatism, excluding the back
Operations on the musculoskeletal system
General symptoms
Symptoms involving nervous and musculoskeletal systems
Symptoms involving skin and other integumentary tissue
Symptoms involving head and neck
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Nonspecific abnormal findings on radiological and other examination of body structure
Ill-defined and unknown causes of morbidity and mortality
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Anticonvulsants
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antiparkinson Agents
Antipruritics
Antipsychotic Agents
Antipyretics
Bronchodilator Agents
Calcium Channel Blockers
Cathartics
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Diuretics
Drug Carriers
Excitatory Amino Acid Antagonists
Explosive Agents
Fibrinolytic Agents
GABA Modulators
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Nitric Oxide Donors
Parasympatholytics
Phosphodiesterase Inhibitors
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Solvents
Surface-Active Agents
Sympatholytics
Tocolytic Agents
Vasodilator Agents
===== phenotype 10=================================================================
proportion of pts: 0.0864736215787
lambda: 26684.0835748
----------------------------------------
Other bacterial diseases
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Coagulation or hemorrhagic diseases
Other diseases of the blood
Na
Neurotic, personality, nonpsychotic disorders
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Pain
Other disorders of the central nervous system
Disorders of the peripheral nervous system
Hypertensive disease
Other forms of heart disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Pneumonia and influenza
Chronic obstructive pulmonary disease and allied conditions
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Hernia of abdominal cavity
Other diseases of intestines and peritoneum
Nephritis, nephrotic syndrome, and nephrosis
Infections of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Congenital anomalies
Operations on the musculoskeletal system
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving head and neck
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Ill-defined and unknown causes of morbidity and mortality
Fractures
Operations on the integumentary system
Other and unspecified effects of external causes
Range name na
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Anesthetics, Local
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Ulcer Agents
Anticoagulants
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antiparkinson Agents
Antipruritics
Antipsychotic Agents
Antipyretics
Antitussive Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiovascular Agents
Cathartics
Cholinergic Antagonists
Diuretics
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
GABA Modulators
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists
Hypnotics and Sedatives
Leprostatic Agents
Muscle Relaxants, Central
Myeloablative Agonists
Narcotics
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Rodenticides
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sweetening Agents
Sympatholytics
Sympathomimetics
Tocolytic Agents
Topoisomerase II Inhibitors
Vasoconstrictor Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 41=================================================================
proportion of pts: 0.10749702499
lambda: 26481.1469323
----------------------------------------
Intestinal infectious diseases
Mycoses
Diabetes
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Coagulation or hemorrhagic diseases
Other diseases of the blood
Drug dependence
Hypertensive disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Other diseases of respiratory system
Other diseases of intestines and peritoneum
Liver
Other diseases of digestive system
Nephritis, nephrotic syndrome, and nephrosis
Other diseases of urinary system
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms concerning nutrition, metabolism, and development
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Abnormal results of function studies
Miscellaneous diagnostic and therapeutic procedures
----------------------------------------
Adjuvants, Anesthesia
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Antidepressive Agents, Second-Generation
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimetabolites
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antiprotozoal Agents
Antipruritics
Antipsychotic Agents
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Antagonists
Drug Carriers
Fibrinolytic Agents
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Hypoglycemic Agents
Ionophores
Mineralocorticoid Receptor Antagonists
Narcotics
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Radiation-Sensitizing Agents
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Solvents
Surface-Active Agents
Sweetening Agents
Tocolytic Agents
Topoisomerase II Inhibitors
Trace Elements
Tubulin Modulators
Vasodilator Agents
Vitamins
===== phenotype 34=================================================================
proportion of pts: 0.124157080524
lambda: 26411.3540232
----------------------------------------
Mycoses
Disorders of thyroid gland
Diabetes
Nutritional deficiencies
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Hypertensive disease
Other forms of heart disease
Cerebrovascular disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Nephritis, nephrotic syndrome, and nephrosis
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Range name na
----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Anticonvulsants
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antiparkinson Agents
Antipyretics
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Diuretics
Excitatory Amino Acid Antagonists
Glucocorticoids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Mineralocorticoid Receptor Antagonists
Muscarinic Antagonists
Muscle Relaxants, Central
Narcotics
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Tranquilizing Agents
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 38=================================================================
proportion of pts: 0.12177707259
lambda: 26138.6576726
----------------------------------------
Mycoses
Disorders of thyroid gland
Diabetes
Nutritional deficiencies
Disorders of lipoid metabolism
Gout
Other immune disorders
Anemias
Hereditary and degenerative diseases of the central nervous system
Disorders of the peripheral nervous system
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Cerebrovascular disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Nephritis, nephrotic syndrome, and nephrosis
Other diseases of urinary system
Infections of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving nervous and musculoskeletal systems
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Nonspecific findings on examination of urine
Open wound
Na
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antimetabolites
Antioxidants
Antiparkinson Agents
Antipruritics
Antipyretics
Antitussive Agents
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Explosive Agents
Fibrinolytic Agents
Free Radical Scavengers
GABA Modulators
Gastrointestinal Agents
Gout Suppressants
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 21=================================================================
proportion of pts: 0.115033716779
lambda: 26046.8088837
----------------------------------------
Neoplasms of unspecified nature
Disorders of thyroid gland
Nutritional deficiencies
Disorders of lipoid metabolism
Disorders of mineral metabolism
Anemias
Neurotic, personality, nonpsychotic disorders
Disorders of the peripheral nervous system
Diseases of the ear and mastoid process
Hypertensive disease
Other forms of heart disease
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Other diseases of urinary system
Infections of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Congenital anomalies
General symptoms
Symptoms involving nervous and musculoskeletal systems
Symptoms involving skin and other integumentary tissue
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
Nonspecific findings on examination of blood
Fractures
Superficial, contusion, crushing injuries
Na
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antioxidants
Antiparkinson Agents
Antipyretics
Bone Density Conservation Agents
Calcium Channel Blockers
Cyclooxygenase Inhibitors
Diuretics
Dopamine Uptake Inhibitors
Estrogens
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
GABA Modulators
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Narcotics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 5=================================================================
proportion of pts: 0.132090440301
lambda: 24825.8081682
----------------------------------------
Diabetes
Other disorders of pancreatic internal secretion
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Other diseases of the blood
Disorders of the eye and adnexa
Chronic rheumatic heart disease
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Cerebrovascular disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of respiratory system
Nephritis, nephrotic syndrome, and nephrosis
Congenital anomalies
General symptoms
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Abnormal results of function studies
Other and unspecified effects of external causes
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Antihypertensive Agents
Antineoplastic Agents
Antioxidants
Antipyretics
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Explosive Agents
Fibrinolytic Agents
Hematinics
Hemostatics
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Narcotics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Tissue Adhesives
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 16=================================================================
proportion of pts: 0.113843712812
lambda: 24818.0931693
----------------------------------------
Malignant neoplasm of respiratory and intrathoracic organs
Diabetes
Diseases of other endocrine glands
Nutritional deficiencies
Disorders of lipoid metabolism
Anemias
Operations on the respiratory system
Drug dependence
Organic sleep disorders
Hypertensive disease
Ischemic heart disease
Diseases of pulmonary circulation
Other forms of heart disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of the upper respiratory tract
Pneumonia and influenza
Chronic obstructive pulmonary disease and allied conditions
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Nephritis, nephrotic syndrome, and nephrosis
Other diseases of urinary system
Diseases of male genital organs
Dorsopathies
Rheumatism, excluding the back
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Ill-defined and unknown causes of morbidity and mortality
Range name na
----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics
Analgesics, Non-Narcotic
Androgens
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antiparkinson Agents
Antipyretics
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Expectorants
Explosive Agents
Fibrinolytic Agents
Glucocorticoids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Nitric Oxide Donors
Parasympatholytics
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Sympathomimetics
Tocolytic Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 47=================================================================
proportion of pts: 0.152717175724
lambda: 24102.7460795
----------------------------------------
Diabetes
Disorders of lipoid metabolism
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Ischemic heart disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Diseases of esophagus, stomach, and duodenum
Other disorders of female genital tract
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Sprains and strains of joints and adjacent muscles
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antihypertensive Agents
Antimetabolites, Antineoplastic
Antioxidants
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
Gout Suppressants
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Tocolytic Agents
Vasodilator Agents
Vitamins
===== phenotype 13=================================================================
proportion of pts: 0.157080523602
lambda: 23815.2838211
----------------------------------------
Diabetes
Nutritional deficiencies
Disorders of lipoid metabolism
Anemias
Na
Organic sleep disorders
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Diseases of arteries, arterioles, and capillaries
Acute respiratory infections
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
General symptoms
Nonspecific findings on examination of blood
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antineoplastic Agents, Phytogenic
Antioxidants
Antipyretics
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dipeptidyl-Peptidase IV Inhibitors
Diuretics
Fibrinolytic Agents
Glucocorticoids
Histamine H1 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Incretins
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 25=================================================================
proportion of pts: 0.123760412535
lambda: 23731.4204789
----------------------------------------
Diabetes
Disorders of lipoid metabolism
Anemias
Na
Organic sleep disorders
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Hypertensive disease
Other diseases of the upper respiratory tract
Other diseases of intestines and peritoneum
Other inflammatory conditions of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving head and neck
Sprains and strains of joints and adjacent muscles
Open wound
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antimetabolites, Antineoplastic
Antineoplastic Agents, Hormonal
Antiparkinson Agents
Antipruritics
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
Folic Acid Antagonists
GABA-A Receptor Agonists
Glucocorticoids
Gout Suppressants
Hematinics
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Immunosuppressive Agents
Muscle Relaxants, Central
Narcotics
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 23=================================================================
proportion of pts: 0.0844902816343
lambda: 23495.7164083
----------------------------------------
Operations on the nervous system
Other bacterial diseases
Operations on the nose, mouth, and pharynx
Diabetes
Overweight, obesity and other hyperalimentation
Organic psychotic conditions
Na
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Pain
Other disorders of the central nervous system
Operations on the cardiovascular system
Hypertensive disease
Other forms of heart disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of respiratory system
Other diseases of urinary system
Infections of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Congenital anomalies
Operations on the musculoskeletal system
General symptoms
Symptoms involving nervous and musculoskeletal systems
Symptoms involving cardiovascular system
Symptoms involving urinary system
Nonspecific findings on examination of blood
Nonspecific abnormal findings on radiological and other examination of body structure
Ill-defined and unknown causes of morbidity and mortality
Miscellaneous diagnostic and therapeutic procedures
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic alpha-Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Anticonvulsants
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antiparkinson Agents
Antipruritics
Antipsychotic Agents
Antipyretics
Antitussive Agents
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Diuretics
Dopamine Antagonists
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
Gastrointestinal Agents
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Muscle Relaxants, Central
Narcotics
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Rodenticides
Serotonin Antagonists
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sweetening Agents
Sympatholytics
Topoisomerase II Inhibitors
Tranquilizing Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 42=================================================================
proportion of pts: 0.112257040857
lambda: 23435.116458
----------------------------------------
Disorders of thyroid gland
Nutritional deficiencies
Disorders of lipoid metabolism
Na
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Other disorders of the central nervous system
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Diseases of esophagus, stomach, and duodenum
Other diseases of intestines and peritoneum
Other inflammatory conditions of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of blood
Abnormal results of function studies
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Anesthetics, Local
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antineoplastic Agents, Hormonal
Antiparkinson Agents
Antipruritics
Antipsychotic Agents
Bronchodilator Agents
Calcium Channel Blockers
Cyclooxygenase Inhibitors
Dermatologic Agents
Dopamine Uptake Inhibitors
Estrogens
Excitatory Amino Acid Antagonists
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hypnotics and Sedatives
Muscarinic Antagonists
Muscle Relaxants, Central
Narcotics
Neuroprotective Agents
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sympatholytics
Voltage-Gated Sodium Channel Blockers
===== phenotype 37=================================================================
proportion of pts: 0.123760412535
lambda: 23166.5754272
----------------------------------------
Nutritional deficiencies
Disorders of lipoid metabolism
Organic psychotic conditions
Na
Other psychoses
Neurotic, personality, nonpsychotic disorders
Drug dependence
Organic sleep disorders
Pain
Disorders of the peripheral nervous system
Hypertensive disease
Ischemic heart disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Pneumonia and influenza
Chronic obstructive pulmonary disease and allied conditions
Diseases of oral cavity, salivary glands, and jaws
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Sprains and strains of joints and adjacent muscles
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antioxidants
Antiparkinson Agents
Antipruritics
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Uptake Inhibitors
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Muscle Relaxants, Central
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sympatholytics
Tocolytic Agents
Tranquilizing Agents
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 9=================================================================
proportion of pts: 0.134867116224
lambda: 22501.6343898
----------------------------------------
Mycoses
Diabetes
Nutritional deficiencies
Disorders of lipoid metabolism
Other and unspecified disorders of metabolism
Organic sleep disorders
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Other diseases of the upper respiratory tract
Other diseases of urinary system
Infections of skin and subcutaneous tissue
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
Sprains and strains of joints and adjacent muscles
Superficial, contusion, crushing injuries
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
14-alpha Demethylase Inhibitors
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Second-Generation
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Fibrinolytic Agents
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 0=================================================================
proportion of pts: 0.134470448235
lambda: 22133.7434116
----------------------------------------
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Organic psychotic conditions
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Other disorders of the central nervous system
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Other forms of heart disease
Cerebrovascular disease
Other diseases of urinary system
Diseases of male genital organs
Arthropathies and related disorders
Dorsopathies
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Operations on the musculoskeletal system
General symptoms
Na
Symptoms involving nervous and musculoskeletal systems
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of blood
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antioxidants
Antiparkinson Agents
Antipyretics
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cholinesterase Inhibitors
Cyclooxygenase Inhibitors
Diuretics
Dopamine Agonists
Explosive Agents
Fibrinolytic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Muscarinic Antagonists
Nootropic Agents
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sympatholytics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 40=================================================================
proportion of pts: 0.0702102340341
lambda: 21697.7685111
----------------------------------------
nan
Diabetes
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Coagulation or hemorrhagic diseases
Drug dependence
Operations on the cardiovascular system
Hypertensive disease
Ischemic heart disease
Diseases of pulmonary circulation
Other forms of heart disease
Diseases of arteries, arterioles, and capillaries
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Other diseases of urinary system
Operations on the musculoskeletal system
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Ill-defined and unknown causes of morbidity and mortality
Miscellaneous diagnostic and therapeutic procedures
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antiemetics
Antihypertensive Agents
Antimalarials
Antioxidants
Antipruritics
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Explosive Agents
Fibrinolytic Agents
Folic Acid Antagonists
GABA Modulators
Hemostatics
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Leprostatic Agents
Muscarinic Antagonists
Muscle Relaxants, Central
Narcotics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sweetening Agents
Sympatholytics
Sympathomimetics
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 20=================================================================
proportion of pts: 0.122173740579
lambda: 21211.5164613
----------------------------------------
Mycoses
Malignant neoplasm of skin
Benign neoplasm of skin
Neoplasm of uncertain behavior of other sites & tissues
Nutritional deficiencies
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Diseases of arteries, arterioles, and capillaries
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of urinary system
Infections of skin and subcutaneous tissue
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
Fractures
Sprains and strains of joints and adjacent muscles
Open wound
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimetabolites
Antineoplastic Agents, Hormonal
Antioxidants
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Glucocorticoids
Gout Suppressants
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunosuppressive Agents
Narcotics
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 2=================================================================
proportion of pts: 0.133677112257
lambda: 20781.5362378
----------------------------------------
Diseases of other endocrine glands
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Diseases of the ear and mastoid process
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Acute respiratory infections
Pneumonia and influenza
Disorders of breast
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Operations on the musculoskeletal system
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Nonspecific abnormal findings on radiological and other examination of body structure
Abnormal results of function studies
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Glucocorticoids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Mineralocorticoid Receptor Antagonists
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Rodenticides
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Vasodilator Agents
Vitamins
===== phenotype 8=================================================================
proportion of pts: 0.104720349068
lambda: 20714.6223921
----------------------------------------
Other bacterial diseases
Operations on the nose, mouth, and pharynx
Diabetes
Nutritional deficiencies
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Operations on the digestive system
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Hernia of abdominal cavity
Other diseases of intestines and peritoneum
Other diseases of digestive system
Dorsopathies
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Congenital anomalies
Operations on the musculoskeletal system
General symptoms
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Nonspecific abnormal findings on radiological and other examination of body structure
Abnormal results of function studies
Certain traumatic complications and unspecified injuries
Other and unspecified effects of external causes
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antioxidants
Antipruritics
Antipsychotic Agents
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cathartics
Cyclooxygenase Inhibitors
Explosive Agents
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Histamine H1 Antagonists
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Indicators and Reagents
Muscarinic Antagonists
Muscle Relaxants, Central
Mydriatics
Narcotics
Parasympatholytics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Antagonists
Serotonin Uptake Inhibitors
Trace Elements
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 17=================================================================
proportion of pts: 0.110273700912
lambda: 20600.278738
----------------------------------------
Viral diseases accompanied by exanthem
Malignant neoplasm of skin
Malignant neoplasm of male and female genital organs
Malignant neoplasm of badder, kidney and other urinary organs
Benign neoplasm of other parts of digestive system
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Gout
Anemias
Organic sleep disorders
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Operations on the digestive system
Other forms of heart disease
Hernia of abdominal cavity
Other diseases of intestines and peritoneum
Other diseases of digestive system
Other diseases of urinary system
Diseases of male genital organs
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Range name na
----------------------------------------
5-alpha Reductase Inhibitors
Adjuvants, Anesthesia
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Anticonvulsants
Antihypertensive Agents
Antimetabolites
Antineoplastic Agents, Hormonal
Antipyretics
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Free Radical Scavengers
GABA Modulators
Glucocorticoids
Gout Suppressants
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Narcotics
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Rodenticides
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Tocolytic Agents
Tubulin Modulators
Urological Agents
Vasodilator Agents
Vitamins
===== phenotype 33=================================================================
proportion of pts: 0.10749702499
lambda: 20203.5793631
----------------------------------------
Other bacterial diseases
Mycoses
Disorders of thyroid gland
Disorders of fluid, electrolyte, and acid-base balance
Hereditary and degenerative diseases of the central nervous system
Other disorders of the central nervous system
Hypertensive disease
Other forms of heart disease
Cerebrovascular disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Acute respiratory infections
Other diseases of the upper respiratory tract
Pneumonia and influenza
Chronic obstructive pulmonary disease and allied conditions
Other diseases of respiratory system
Other diseases of urinary system
Other disorders of female genital tract
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Dorsopathies
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving nervous and musculoskeletal systems
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Ill-defined and unknown causes of morbidity and mortality
Late effects of injuries, poisonings, toxic effects, and other external causes
Certain traumatic complications and unspecified injuries
----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic beta-2 Receptor Agonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Second-Generation
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antineoplastic Agents, Hormonal
Antiparkinson Agents
Antipruritics
Antipyretics
Antirheumatic Agents
Antiviral Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Expectorants
Fibrinolytic Agents
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Immunosuppressive Agents
Ionophores
Muscle Relaxants, Central
Narcotics
Neuroprotective Agents
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Tocolytic Agents
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamins
===== phenotype 49=================================================================
proportion of pts: 0.117810392701
lambda: 20119.4486123
----------------------------------------
Viral diseases accompanied by exanthem
Disorders of thyroid gland
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Coagulation or hemorrhagic diseases
Organic sleep disorders
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Other forms of heart disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Other diseases of intestines and peritoneum
Other inflammatory conditions of skin and subcutaneous tissue
Arthropathies and related disorders
General symptoms
Na
Symptoms involving skin and other integumentary tissue
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Antagonists
Analgesics
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticoagulants
Anticonvulsants
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antiparkinson Agents
Antipruritics
Antipyretics
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Expectorants
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hypnotics and Sedatives
Leukotriene Antagonists
Lipoxygenase Inhibitors
Proton Pump Inhibitors
Rodenticides
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Sympathomimetics
Tocolytic Agents
Vasodilator Agents
Vitamin B Complex
Voltage-Gated Sodium Channel Blockers
===== phenotype 4=================================================================
proportion of pts: 0.105910353035
lambda: 20071.2946979
----------------------------------------
Diabetes
Diseases of other endocrine glands
Nutritional deficiencies
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Overweight, obesity and other hyperalimentation
Anemias
Other diseases of the blood
Na
Neurotic, personality, nonpsychotic disorders
Organic sleep disorders
Other disorders of the central nervous system
Hypertensive disease
Diseases of arteries, arterioles, and capillaries
Acute respiratory infections
Pneumonia and influenza
Chronic obstructive pulmonary disease and allied conditions
Noninfectious enteritis and colitis
Other diseases of digestive system
Nephritis, nephrotic syndrome, and nephrosis
Disorders of breast
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Symptoms involving skin and other integumentary tissue
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Other and unspecified effects of external causes
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antineoplastic Agents, Phytogenic
Antioxidants
Antiparkinson Agents
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Central Nervous System Stimulants
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Uptake Inhibitors
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Muscle Relaxants, Central
Neuroprotective Agents
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Tocolytic Agents
Trace Elements
Tranquilizing Agents
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 18=================================================================
proportion of pts: 0.109480364935
lambda: 19889.2748581
----------------------------------------
Viral diseases accompanied by exanthem
Mycoses
Malignant neoplasm of skin
Operations on the nose, mouth, and pharynx
Benign neoplasm of skin
Neoplasm of uncertain behavior of other sites & tissues
Disorders of thyroid gland
Diabetes
Diseases of other endocrine glands
Disorders of lipoid metabolism
Organic psychotic conditions
Na
Other psychoses
Neurotic, personality, nonpsychotic disorders
Hereditary and degenerative diseases of the central nervous system
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Other forms of heart disease
Cerebrovascular disease
Diseases of arteries, arterioles, and capillaries
Acute respiratory infections
Chronic obstructive pulmonary disease and allied conditions
Other disorders of female genital tract
Infections of skin and subcutaneous tissue
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Rheumatism, excluding the back
General symptoms
Na
Symptoms involving skin and other integumentary tissue
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antimanic Agents
Antimetabolites, Antineoplastic
Antiparkinson Agents
Antipsychotic Agents
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Calcium Channel Blockers
Cholinesterase Inhibitors
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Agents
Dopamine Antagonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
Folic Acid Antagonists
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Nootropic Agents
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Vasodilator Agents
Vitamins
===== phenotype 46=================================================================
proportion of pts: 0.13248710829
lambda: 19801.945809
----------------------------------------
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Gout
Overweight, obesity and other hyperalimentation
Organic sleep disorders
Disorders of the peripheral nervous system
Diseases of the ear and mastoid process
Hypertensive disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Diseases of esophagus, stomach, and duodenum
Other diseases of intestines and peritoneum
Arthropathies and related disorders
Dorsopathies
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Other symptoms involving abdomen and pelvis
Nonspecific abnormal findings on radiological and other examination of body structure
Range name na
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antioxidants
Antipruritics
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Uptake Inhibitors
Drug Carriers
Enzyme Inhibitors
Fibrinolytic Agents
Gout Suppressants
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Mineralocorticoid Receptor Antagonists
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Solvents
Surface-Active Agents
Sympatholytics
Vasodilator Agents
Vitamins
===== phenotype 22=================================================================
proportion of pts: 0.121380404601
lambda: 19797.9202161
----------------------------------------
Disorders of lipoid metabolism
Overweight, obesity and other hyperalimentation
Na
Neurotic, personality, nonpsychotic disorders
Organic sleep disorders
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Diseases of esophagus, stomach, and duodenum
Other diseases of urinary system
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Symptoms involving skin and other integumentary tissue
Symptoms concerning nutrition, metabolism, and development
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Angiotensin II Type 1 Receptor Blockers
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antineoplastic Agents, Hormonal
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Central Nervous System Stimulants
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Food Additives
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Leukotriene Antagonists
Lipoxygenase Inhibitors
Phosphodiesterase Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Sympathomimetics
Tocolytic Agents
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamins
===== phenotype 11=================================================================
proportion of pts: 0.133280444268
lambda: 19755.9799559
----------------------------------------
Diabetes
Disorders of lipoid metabolism
Anemias
Organic sleep disorders
Pain
Disorders of the peripheral nervous system
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Chronic obstructive pulmonary disease and allied conditions
Diseases of oral cavity, salivary glands, and jaws
Other diseases of intestines and peritoneum
Other diseases of urinary system
Disorders of breast
Other disorders of female genital tract
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of blood
Nonspecific abnormal findings on radiological and other examination of body structure
Range name na
----------------------------------------
14-alpha Demethylase Inhibitors
Abortifacient Agents, Nonsteroidal
Adrenergic alpha-2 Receptor Agonists
Analgesics
Analgesics, Opioid
Anesthetics, Local
Antacids
Anti-Anxiety Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Antifungal Agents
Antimalarials
Antimetabolites, Antineoplastic
Antineoplastic Agents, Hormonal
Antipruritics
Antipsychotic Agents
Antirheumatic Agents
Antitussive Agents
Bone Density Conservation Agents
Central Nervous System Stimulants
Dermatologic Agents
Detergents
Drug Carriers
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Folic Acid Antagonists
Gastrointestinal Agents
Immunosuppressive Agents
Muscarinic Antagonists
Muscle Relaxants, Central
Mutagens
Myeloablative Agonists
Narcotics
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Phosphodiesterase Inhibitors
Preservatives, Pharmaceutical
Protein Synthesis Inhibitors
Purinergic P1 Receptor Antagonists
Solvents
Surface-Active Agents
Topoisomerase II Inhibitors
Trace Elements
Tubulin Modulators
Voltage-Gated Sodium Channel Blockers
===== phenotype 1=================================================================
proportion of pts: 0.113050376835
lambda: 19748.7733744
----------------------------------------
Viral diseases accompanied by exanthem
Benign neoplasm of other parts of digestive system
Diabetes
Nutritional deficiencies
Disorders of lipoid metabolism
Gout
Overweight, obesity and other hyperalimentation
Na
Drug dependence
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Disorders of the eye and adnexa
Hypertensive disease
Diseases of esophagus, stomach, and duodenum
Liver
Nephritis, nephrotic syndrome, and nephrosis
Infections of skin and subcutaneous tissue
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Abnormal results of function studies
Range name na
----------------------------------------
Adrenergic Uptake Inhibitors
Adrenergic alpha-2 Receptor Agonists
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimalarials
Antimanic Agents
Antimetabolites
Antineoplastic Agents, Phytogenic
Antioxidants
Antiparkinson Agents
Antipyretics
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Diuretics
Dopamine Agonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Excitatory Amino Acid Antagonists
Fibrinolytic Agents
Free Radical Scavengers
GABA-A Receptor Agonists
Gout Suppressants
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Mineralocorticoid Receptor Antagonists
Muscle Relaxants, Central
Narcotics
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Tocolytic Agents
Tubulin Modulators
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 15=================================================================
proportion of pts: 0.106307021023
lambda: 19747.1729169
----------------------------------------
Malignant neoplasm of badder, kidney and other urinary organs
Disorders of thyroid gland
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Neurotic, personality, nonpsychotic disorders
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Pain
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Hypertensive disease
Cerebrovascular disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Other diseases of urinary system
Diseases of male genital organs
Infections of skin and subcutaneous tissue
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving head and neck
Symptoms involving urinary system
Nonspecific findings on examination of blood
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
5-alpha Reductase Inhibitors
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Agonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Agonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimanic Agents
Antiparkinson Agents
Antipruritics
Antipyretics
Antiviral Agents
Bronchodilator Agents
Calcium Channel Blockers
Cholinergic Antagonists
Cyclooxygenase Inhibitors
Dermatologic Agents
Excitatory Amino Acid Antagonists
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Leukotriene Antagonists
Lipoxygenase Inhibitors
Muscarinic Antagonists
Muscle Relaxants, Central
Mydriatics
Narcotics
Nasal Decongestants
Parasympatholytics
Phosphodiesterase Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Surface-Active Agents
Sympathomimetics
Tocolytic Agents
Topoisomerase II Inhibitors
Tranquilizing Agents
Urological Agents
Vasoconstrictor Agents
Vasodilator Agents
Voltage-Gated Sodium Channel Blockers
===== phenotype 27=================================================================
proportion of pts: 0.128123760413
lambda: 19509.1609439
----------------------------------------
Other bacterial diseases
Operations on the nose, mouth, and pharynx
Benign neoplasm of other parts of digestive system
Disorders of thyroid gland
Nutritional deficiencies
Disorders of lipoid metabolism
Anemias
Other diseases of the blood
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Other forms of heart disease
Cerebrovascular disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Other diseases of intestines and peritoneum
Other diseases of urinary system
Other disorders of female genital tract
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms involving head and neck
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of urine
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Local
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antihypertensive Agents
Antioxidants
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Detergents
Diuretics
Fibrinolytic Agents
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Parasympatholytics
Platelet Aggregation Inhibitors
Preservatives, Pharmaceutical
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Solvents
Surface-Active Agents
Sympatholytics
Tocolytic Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 48=================================================================
proportion of pts: 0.120983736612
lambda: 19438.8869538
----------------------------------------
Other diseases due to viruses and chlamydiae
Hemangioma and lymphangioma any site
Disorders of thyroid gland
Nutritional deficiencies
Disorders of lipoid metabolism
Anemias
Organic sleep disorders
Hypertensive disease
Cerebrovascular disease
Diseases of arteries, arterioles, and capillaries
Acute respiratory infections
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Diseases of esophagus, stomach, and duodenum
Disorders of breast
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of blood
Abnormal results of function studies
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antihypertensive Agents
Antimetabolites, Antineoplastic
Antineoplastic Agents, Hormonal
Antioxidants
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiovascular Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
Glucocorticoids
Gout Suppressants
Hematinics
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunosuppressive Agents
Lipoxygenase Inhibitors
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Sodium Chloride Symporter Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 6=================================================================
proportion of pts: 0.0979769932566
lambda: 19302.5709819
----------------------------------------
Other diseases due to viruses and chlamydiae
Benign neoplasm of breast, ovary, uterus, and other genitourinary organs
Disorders of thyroid gland
Diseases of other endocrine glands
Nutritional deficiencies
Overweight, obesity and other hyperalimentation
Na
Other psychoses
Neurotic, personality, nonpsychotic disorders
Drug dependence
Organic sleep disorders
Hypertensive disease
Operations on the digestive system
Acute respiratory infections
Diseases of esophagus, stomach, and duodenum
Operations on the urinary system
Other diseases of intestines and peritoneum
Liver
Gallbladder
Other diseases of urinary system
Other disorders of female genital tract
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Other symptoms involving abdomen and pelvis
Miscellaneous diagnostic and therapeutic procedures
Range name na
----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiemetics
Antihypertensive Agents
Antioxidants
Antipruritics
Antipsychotic Agents
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Antagonists
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Immunosuppressive Agents
Muscarinic Antagonists
Mydriatics
Narcotics
Parasympatholytics
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Vasoconstrictor Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 14=================================================================
proportion of pts: 0.11106703689
lambda: 19191.3077998
----------------------------------------
Other bacterial diseases
Malignant neoplasm of digestive organs and peritoneum
Malignant neoplasm of badder, kidney and other urinary organs
Disorders of thyroid gland
Disorders of lipoid metabolism
Gout
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Neurotic, personality, nonpsychotic disorders
Diseases of the ear and mastoid process
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Diseases of arteries, arterioles, and capillaries
Diseases of veins and lymphatics, and other diseases of circulatory system
Pneumonia and influenza
Diseases of oral cavity, salivary glands, and jaws
Diseases of esophagus, stomach, and duodenum
Other diseases of intestines and peritoneum
Nephritis, nephrotic syndrome, and nephrosis
Other diseases of urinary system
Operations on the musculoskeletal system
General symptoms
Symptoms involving cardiovascular system
Symptoms involving urinary system
Nonspecific findings on examination of blood
Nonspecific findings on examination of urine
Abnormal results of function studies
Operations on the integumentary system
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimalarials
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
Free Radical Scavengers
Glucocorticoids
Gout Suppressants
Hematinics
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Immunosuppressive Agents
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Rodenticides
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 35=================================================================
proportion of pts: 0.104720349068
lambda: 19137.1464962
----------------------------------------
Operations on the nose, mouth, and pharynx
Benign neoplasm of other parts of digestive system
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Organic sleep disorders
Other disorders of the central nervous system
Diseases of the ear and mastoid process
Hypertensive disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Diseases of esophagus, stomach, and duodenum
Other diseases of urinary system
Disorders of breast
Other disorders of female genital tract
Infections of skin and subcutaneous tissue
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Dislocation
Sprains and strains of joints and adjacent muscles
Effects of foreign body entering through orifice
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic beta-2 Receptor Agonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticonvulsants
Antidepressive Agents, Second-Generation
Antiemetics
Antihypertensive Agents
Antimalarials
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antipruritics
Antipyretics
Antirheumatic Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Estrogens
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hypnotics and Sedatives
Hypoglycemic Agents
Immunosuppressive Agents
Leukotriene Antagonists
Muscarinic Antagonists
Muscle Relaxants, Central
Mydriatics
Narcotics
Neuroprotective Agents
Parasympatholytics
Proton Pump Inhibitors
Serotonin 5-HT1 Receptor Agonists
Serotonin Uptake Inhibitors
Sympathomimetics
Tocolytic Agents
Topoisomerase II Inhibitors
Vasoconstrictor Agents
===== phenotype 12=================================================================
proportion of pts: 0.112257040857
lambda: 18982.6475635
----------------------------------------
Malignant neoplasm of skin
Diabetes
Disorders of lipoid metabolism
Overweight, obesity and other hyperalimentation
Other diseases of the blood
Organic sleep disorders
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Gallbladder
Other diseases of urinary system
Infections of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Fractures
Miscellaneous diagnostic and therapeutic procedures
Superficial, contusion, crushing injuries
Na
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Antiemetics
Antihypertensive Agents
Antioxidants
Antipruritics
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Explosive Agents
Fibrinolytic Agents
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipoxygenase Inhibitors
Mineralocorticoid Receptor Antagonists
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Rodenticides
Sodium Potassium Chloride Symporter Inhibitors
Surface-Active Agents
Sympatholytics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 36=================================================================
proportion of pts: 0.103133677112
lambda: 18875.9719169
----------------------------------------
Mycoses
Lipoma and other benign neoplasm of connective and other soft tissue
Disorders of lipoid metabolism
Other immune disorders
Anemias
Pain
Other disorders of the central nervous system
Disorders of the eye and adnexa
Hypertensive disease
Diseases of esophagus, stomach, and duodenum
Other diseases of intestines and peritoneum
Other diseases of urinary system
Inflammatory disease of female pelvic organs
Other disorders of female genital tract
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms concerning nutrition, metabolism, and development
Symptoms involving head and neck
Symptoms involving digestive system
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of urine
Other nonspecific abnormal findings
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic Uptake Inhibitors
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Diuretics
Dopamine Uptake Inhibitors
Drug Carriers
Estrogens
Fibrinolytic Agents
GABA Modulators
Glucocorticoids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Muscarinic Antagonists
Muscle Relaxants, Central
Narcotics
Neuroprotective Agents
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Solvents
Surface-Active Agents
Topoisomerase II Inhibitors
Tranquilizing Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 3=================================================================
proportion of pts: 0.11106703689
lambda: 18622.9439061
----------------------------------------
Secondary malignant neoplasm of lymph nodes, digestive system and other specified sites
Benign neoplasm of other parts of digestive system
Disorders of thyroid gland
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Hypertensive disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of respiratory system
Diseases of esophagus, stomach, and duodenum
Hernia of abdominal cavity
Noninfectious enteritis and colitis
Other diseases of intestines and peritoneum
Other diseases of digestive system
Other diseases of urinary system
Rheumatism, excluding the back
Congenital anomalies
General symptoms
Symptoms concerning nutrition, metabolism, and development
Symptoms involving digestive system
Other symptoms involving abdomen and pelvis
Nonspecific abnormal findings in other body substances
Fractures
Open wound
Injury to nerves and spinal cord
Certain traumatic complications and unspecified injuries
Complications of surgical and medical care, not elsewhere classified
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticoagulants
Anticonvulsants
Antidepressive Agents, Second-Generation
Antiemetics
Antihypertensive Agents
Antiprotozoal Agents
Antipruritics
Antipsychotic Agents
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cathartics
Cyclooxygenase Inhibitors
Diuretics
Drug Carriers
Fibrinolytic Agents
GABA Modulators
GABA-A Receptor Agonists
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Muscle Relaxants, Central
Narcotics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Radiation-Sensitizing Agents
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Solvents
Surface-Active Agents
Sympatholytics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamins
===== phenotype 30=================================================================
proportion of pts: 0.122570408568
lambda: 18440.6977868
----------------------------------------
Disorders of thyroid gland
Disorders of lipoid metabolism
Neurotic, personality, nonpsychotic disorders
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Diseases of arteries, arterioles, and capillaries
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of respiratory system
Nephritis, nephrotic syndrome, and nephrosis
Diseases of male genital organs
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Na
Symptoms involving head and neck
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Ill-defined and unknown causes of morbidity and mortality
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Adjuvants, Anesthesia
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticholesteremic Agents
Anticoagulants
Antidepressive Agents, Second-Generation
Antiemetics
Antihypertensive Agents
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antipruritics
Antipsychotic Agents
Antipyretics
Antirheumatic Agents
Antitussive Agents
Bronchodilator Agents
Cardiotonic Agents
Central Nervous System Stimulants
Cyclooxygenase Inhibitors
Dermatologic Agents
Dopamine Uptake Inhibitors
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
GABA-A Receptor Agonists
Gastrointestinal Agents
Hematinics
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Immunosuppressive Agents
Muscarinic Antagonists
Mutagens
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Platelet Aggregation Inhibitors
Rodenticides
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sympatholytics
Topoisomerase II Inhibitors
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
===== phenotype 39=================================================================
proportion of pts: 0.130107100357
lambda: 17823.2845019
----------------------------------------
Malignant neoplasm of male and female genital organs
Nutritional deficiencies
Disorders of lipoid metabolism
Anemias
Na
Neurotic, personality, nonpsychotic disorders
Hereditary and degenerative diseases of the central nervous system
Disorders of the eye and adnexa
Hypertensive disease
Other diseases of urinary system
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving urinary system
Nonspecific findings on examination of blood
Fractures
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Adjuvants, Immunologic
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antifungal Agents
Antihypertensive Agents
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antioxidants
Antipruritics
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Estrogens
Fibrinolytic Agents
Folic Acid Antagonists
GABA-A Receptor Agonists
Glucocorticoids
Hematinics
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Immunosuppressive Agents
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Trace Elements
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 24=================================================================
proportion of pts: 0.103133677112
lambda: 17709.050207
----------------------------------------
Other bacterial diseases
Diabetes
Disorders of lipoid metabolism
Gout
Disorders of mineral metabolism
Disorders of fluid, electrolyte, and acid-base balance
Overweight, obesity and other hyperalimentation
Other diseases of the blood
Neurotic, personality, nonpsychotic disorders
Drug dependence
Organic sleep disorders
Hereditary and degenerative diseases of the central nervous system
Disorders of the eye and adnexa
Diseases of the ear and mastoid process
Hypertensive disease
Ischemic heart disease
Cerebrovascular disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Acute respiratory infections
Other diseases of respiratory system
Diseases of oral cavity, salivary glands, and jaws
Diseases of esophagus, stomach, and duodenum
Infections of skin and subcutaneous tissue
Other inflammatory conditions of skin and subcutaneous tissue
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Operations on the musculoskeletal system
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Fractures
Miscellaneous diagnostic and therapeutic procedures
Open wound
Certain traumatic complications and unspecified injuries
Range name na
----------------------------------------
14-alpha Demethylase Inhibitors
Abortifacient Agents, Nonsteroidal
Adjuvants, Anesthesia
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Anesthetics, Intravenous
Angiotensin II Type 1 Receptor Blockers
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticholesteremic Agents
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antimalarials
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Enzyme Inhibitors
Estrogens
Explosive Agents
Fibrinolytic Agents
Folic Acid Antagonists
Free Radical Scavengers
GABA Modulators
Glucocorticoids
Gout Suppressants
Hematinics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Immunosuppressive Agents
Ionophores
Muscle Relaxants, Central
Nucleic Acid Synthesis Inhibitors
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Purinergic P2Y Receptor Antagonists
Sympatholytics
Tubulin Modulators
Vitamin B Complex
Vitamins
===== phenotype 44=================================================================
proportion of pts: 0.118603728679
lambda: 17379.2852273
----------------------------------------
Mycoses
Benign neoplasm of other parts of digestive system
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Anemias
Coagulation or hemorrhagic diseases
Organic sleep disorders
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Diseases of esophagus, stomach, and duodenum
Other diseases of intestines and peritoneum
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Congenital anomalies
Symptoms concerning nutrition, metabolism, and development
Nonspecific findings on examination of blood
Range name na
----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antifungal Agents
Antihypertensive Agents
Antioxidants
Antipyretics
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Explosive Agents
Fibrinolytic Agents
GABA Modulators
Glucocorticoids
Hematinics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Sodium Chloride Symporter Inhibitors
Sympatholytics
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 29=================================================================
proportion of pts: 0.0999603332011
lambda: 17125.9176919
----------------------------------------
Malignant neoplasm of skin
Malignant neoplasm of lymphatic and hematopoietic tissue
Neoplasm of uncertain behavior of other sites & tissues
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Disorders of plasma protein metabolism
Disorders of fluid, electrolyte, and acid-base balance
Other immune disorders
Anemias
Other diseases of the blood
Hypertensive disease
Diseases of esophagus, stomach, and duodenum
Liver
Other diseases of urinary system
Other disorders of female genital tract
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms concerning nutrition, metabolism, and development
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Symptoms involving urinary system
Other symptoms involving abdomen and pelvis
Nonspecific findings on examination of blood
Poisoning by drugs, medicinal and biological substances
----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Analgesics
Analgesics, Non-Narcotic
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Tricyclic
Antiemetics
Antihypertensive Agents
Antimetabolites, Antineoplastic
Antioxidants
Antiparkinson Agents
Antipruritics
Antipsychotic Agents
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Dopamine Antagonists
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
GABA-A Receptor Agonists
Gastrointestinal Agents
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Muscarinic Antagonists
Parasympatholytics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Antagonists
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Tocolytic Agents
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 45=================================================================
proportion of pts: 0.105117017057
lambda: 16862.8969141
----------------------------------------
Mycoses
Malignant neoplasm of skin
Malignant neoplasm of lymphatic and hematopoietic tissue
Benign neoplasm of skin
Neoplasm of uncertain behavior of other sites & tissues
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Disorders of fluid, electrolyte, and acid-base balance
Anemias
Other diseases of the blood
Na
Neurotic, personality, nonpsychotic disorders
Diseases of the ear and mastoid process
Hypertensive disease
Acute respiratory infections
Diseases of esophagus, stomach, and duodenum
Other diseases of intestines and peritoneum
Disorders of breast
Other disorders of female genital tract
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Rheumatism, excluding the back
General symptoms
Symptoms involving skin and other integumentary tissue
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Nonspecific findings on examination of blood
Range name na
----------------------------------------
14-alpha Demethylase Inhibitors
Adrenergic beta-1 Receptor Antagonists
Analgesics
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Second-Generation
Antiemetics
Antifungal Agents
Antihypertensive Agents
Antimetabolites
Antioxidants
Antipruritics
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Estrogens
Fibrinolytic Agents
Free Radical Scavengers
GABA Modulators
Glucocorticoids
Gout Suppressants
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Histamine H2 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Lipoxygenase Inhibitors
Parasympatholytics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Receptor Agonists
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sympatholytics
Vasodilator Agents
Vitamins
===== phenotype 28=================================================================
proportion of pts: 0.10749702499
lambda: 16631.5689977
----------------------------------------
Malignant neoplasm of skin
Neoplasm of uncertain behavior of other sites & tissues
Disorders of lipoid metabolism
Gout
Na
Organic sleep disorders
Pain
Hypertensive disease
Ischemic heart disease
Cerebrovascular disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Chronic obstructive pulmonary disease and allied conditions
Other diseases of intestines and peritoneum
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Fractures
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic Uptake Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antidepressive Agents, Tricyclic
Antihypertensive Agents
Antimetabolites
Antipyretics
Antitussive Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Diuretics
Enzyme Inhibitors
Explosive Agents
Fibrinolytic Agents
Free Radical Scavengers
GABA Modulators
GABA-A Receptor Agonists
Glucocorticoids
Gout Suppressants
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Muscle Relaxants, Central
Narcotics
Nitric Oxide Donors
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P2Y Receptor Antagonists
Serotonin Uptake Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Sympathomimetics
Vasodilator Agents
Vitamin B Complex
===== phenotype 31=================================================================
proportion of pts: 0.112653708846
lambda: 16176.7235546
----------------------------------------
Other bacterial diseases
Malignant neoplasm of male and female genital organs
Benign neoplasm of other parts of digestive system
Benign neoplasm of skin
Disorders of lipoid metabolism
Overweight, obesity and other hyperalimentation
Other diseases of the blood
Drug dependence
Operations on the hemic and lymphatic system
Hypertensive disease
Ischemic heart disease
Other forms of heart disease
Diseases of arteries, arterioles, and capillaries
Diseases of veins and lymphatics, and other diseases of circulatory system
Other diseases of the upper respiratory tract
Other diseases of respiratory system
Other diseases of intestines and peritoneum
Other diseases of urinary system
Diseases of male genital organs
Infections of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Congenital anomalies
Operations on the musculoskeletal system
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Other and unspecified effects of external causes
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antiemetics
Antihypertensive Agents
Antimalarials
Antioxidants
Antiprotozoal Agents
Antipyretics
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Cathartics
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Fibrinolytic Agents
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Narcotics
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Radiation-Sensitizing Agents
Sodium Chloride Symporter Inhibitors
Sympatholytics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 32=================================================================
proportion of pts: 0.10392701309
lambda: 15998.0180509
----------------------------------------
Other diseases due to viruses and chlamydiae
Diabetes
Disorders of lipoid metabolism
Overweight, obesity and other hyperalimentation
Pain
Disorders of the eye and adnexa
Hypertensive disease
Ischemic heart disease
Other diseases of the upper respiratory tract
Diseases of oral cavity, salivary glands, and jaws
Other diseases of urinary system
Disorders of breast
Other disorders of female genital tract
Other inflammatory conditions of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
General symptoms
Symptoms involving head and neck
Symptoms involving cardiovascular system
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Nonspecific abnormal findings on radiological and other examination of body structure
Abnormal results of function studies
Sprains and strains of joints and adjacent muscles
Certain traumatic complications and unspecified injuries
Other and unspecified effects of external causes
Range name na
----------------------------------------
Adjuvants, Anesthesia
Adrenergic alpha-Agonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Agonists
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antiemetics
Antihypertensive Agents
Antioxidants
Antipyretics
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Explosive Agents
Fibrinolytic Agents
GABA Modulators
Glucocorticoids
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Muscle Relaxants, Central
Mydriatics
Narcotics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin 5-HT1 Receptor Agonists
Sodium Chloride Symporter Inhibitors
Sympatholytics
Sympathomimetics
Vasoconstrictor Agents
Vasodilator Agents
Vitamins
Voltage-Gated Sodium Channel Blockers
===== phenotype 19=================================================================
proportion of pts: 0.0995636652122
lambda: 15711.8196832
----------------------------------------
Intestinal infectious diseases
Mycoses
Malignant neoplasm of breast
Neoplasm of uncertain behavior of endocrine glands & nervous system
Disorders of thyroid gland
Diabetes
Diseases of other endocrine glands
Nutritional deficiencies
Disorders of lipoid metabolism
Disorders of mineral metabolism
Disorders of fluid, electrolyte, and acid-base balance
Neurotic, personality, nonpsychotic disorders
Disorders of the peripheral nervous system
Disorders of the eye and adnexa
Hypertensive disease
Acute respiratory infections
Other diseases of the upper respiratory tract
Hernia of abdominal cavity
Noninfectious enteritis and colitis
Other diseases of intestines and peritoneum
Other diseases of digestive system
Arthropathies and related disorders
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
General symptoms
Symptoms involving head and neck
Symptoms involving respiratory system and other chest symptoms
Symptoms involving digestive system
Other symptoms involving abdomen and pelvis
Nonspecific abnormal findings on radiological and other examination of body structure
Other and nonspecific abnormal cytological, histological, immunological and dna test findings
Range name na
----------------------------------------
Abortifacient Agents, Nonsteroidal
Adrenergic beta-Antagonists
Analgesics, Non-Narcotic
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimetabolites, Antineoplastic
Antineoplastic Agents, Hormonal
Antioxidants
Antipruritics
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
Glucocorticoids
Hematinics
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Lipoxygenase Inhibitors
Mydriatics
Nucleic Acid Synthesis Inhibitors
Parasympatholytics
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sympathomimetics
Tocolytic Agents
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 7=================================================================
proportion of pts: 0.0987703292344
lambda: 15305.6119985
----------------------------------------
Malignant neoplasm of breast
Malignant neoplasm of other and ill-defined sites
Secondary malignant neoplasm of lymph nodes, digestive system and other specified sites
Malignant neoplasm of lymphatic and hematopoietic tissue
Hemangioma and lymphangioma any site
Disorders of thyroid gland
Diabetes
Disorders of lipoid metabolism
Anemias
Other diseases of the blood
Na
Organic sleep disorders
Hypertensive disease
Diseases of veins and lymphatics, and other diseases of circulatory system
Diseases of esophagus, stomach, and duodenum
Noninfectious enteritis and colitis
Diseases of male genital organs
Disorders of breast
Other disorders of female genital tract
Other diseases of skin and subcutaneous tissue
Arthropathies and related disorders
Dorsopathies
Rheumatism, excluding the back
Osteopathies, chondropathies, and acquired musculoskeletal deformities
Congenital anomalies
General symptoms
Symptoms involving skin and other integumentary tissue
Nonspecific findings on examination of blood
Nonspecific abnormal findings on radiological and other examination of body structure
Operations on the integumentary system
Range name na
----------------------------------------
Adrenergic beta-1 Receptor Antagonists
Analgesics, Non-Narcotic
Analgesics, Opioid
Anesthetics, Local
Angiotensin-Converting Enzyme Inhibitors
Antacids
Anti-Allergic Agents
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Anticonvulsants
Antidepressive Agents, Second-Generation
Antiemetics
Antihypertensive Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antioxidants
Antipyretics
Aromatase Inhibitors
Bone Density Conservation Agents
Calcium Channel Blockers
Cardiotonic Agents
Central Nervous System Stimulants
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Estrogen Antagonists
Fibrinolytic Agents
Food Additives
GABA Modulators
GABA-A Receptor Agonists
Glucocorticoids
Histamine H1 Antagonists
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypolipidemic Agents
Immunosuppressive Agents
Narcotics
Phosphodiesterase Inhibitors
Platelet Aggregation Inhibitors
Proton Pump Inhibitors
Purinergic P1 Receptor Antagonists
Selective Estrogen Receptor Modulators
Serotonin Uptake Inhibitors
Surface-Active Agents
Sympatholytics
Tubulin Modulators
Vasodilator Agents
Vitamin B Complex
Vitamins
===== phenotype 43=================================================================
proportion of pts: 0.107893692979
lambda: 15224.8843342
----------------------------------------
Other diseases due to viruses and chlamydiae
Operations on the eye
Malignant neoplasm of badder, kidney and other urinary organs
Benign neoplasm of other parts of digestive system
Disorders of thyroid gland
Diseases of other endocrine glands
Disorders of lipoid metabolism
Anemias
Coagulation or hemorrhagic diseases
Disorders of the eye and adnexa
Hypertensive disease
Acute respiratory infections
Other diseases of respiratory system
Diseases of oral cavity, salivary glands, and jaws
Hernia of abdominal cavity
Other diseases of intestines and peritoneum
Diseases of male genital organs
Infections of skin and subcutaneous tissue
Other diseases of skin and subcutaneous tissue
General symptoms
Symptoms concerning nutrition, metabolism, and development
Symptoms involving respiratory system and other chest symptoms
Other symptoms involving abdomen and pelvis
Range name na
----------------------------------------
Adrenergic alpha-1 Receptor Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-Antagonists
Analgesics
Analgesics, Non-Narcotic
Androgens
Angiotensin-Converting Enzyme Inhibitors
Anti-Allergic Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Anticholesteremic Agents
Antidepressive Agents, Second-Generation
Antihypertensive Agents
Antimalarials
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antioxidants
Antipyretics
Antirheumatic Agents
Bone Density Conservation Agents
Bronchodilator Agents
Calcium Channel Blockers
Cardiotonic Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Diuretics
Enzyme Inhibitors
Fibrinolytic Agents
Folic Acid Antagonists
Glucocorticoids
Histamine H1 Antagonists, Non-Sedating
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypnotics and Sedatives
Hypoglycemic Agents
Hypolipidemic Agents
Immunosuppressive Agents
Nucleic Acid Synthesis Inhibitors
Phosphodiesterase 5 Inhibitors
Platelet Aggregation Inhibitors
Protein Synthesis Inhibitors
Proton Pump Inhibitors
Serotonin Uptake Inhibitors
Sodium Chloride Symporter Inhibitors
Sodium Potassium Chloride Symporter Inhibitors
Sympatholytics
Topoisomerase II Inhibitors
Vasodilator Agents
Vitamins
